- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: IL15
Total 17 results
-
National Cancer Institute (NCI)CompletedHead and Neck Squamous Cell Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Renal Cell Carcinoma | Recurrent Skin Carcinoma | Stage III Renal Cell Cancer | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Non-Small Cell Lung Carcinoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Stage IV... and other conditionsUnited States
-
Kai Lin Xu; Jun Nian ZhengFirst Affiliated Hospital of Zhejiang University; Nantong University; Affiliated... and other collaboratorsRecruitingB-cell Lymphoma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic LeukemiaChina
-
SUNHO(China)BioPharmaceutical CO., Ltd.RecruitingAdvanced Malignant TumorsChina
-
Nkarta Inc.RecruitingLymphoma, Non-Hodgkin | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | B-cell Acute Lymphoblastic Leukemia | Small Lymphocytic Lymphoma | Large B-cell Lymphoma | Indolent Lymphoma | Aggressive Lymphoma | Large-cell LymphomaUnited States, Australia
-
Senti BiosciencesRecruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological MalignanciesUnited States, Australia
-
Nkarta Inc.Active, not recruitingMDS | AML, Adult | Relapsed/Refractory AML | Refractory Myelodysplastic SyndromesUnited States
-
University Hospital, AntwerpKom Op Tegen Kanker; Stichting tegen KankerRecruitingEsophageal Cancer | Ovarian Cancer | Pancreas Cancer | Liver CancerBelgium
-
Baylor Research InstituteNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedMalignant Melanoma Stage III | Malignant Melanoma Stage IVUnited States
-
Chongqing Public Health Medical CenterZhejiang Qixin Biotech; Chongqing Sidemu BiotechUnknown
-
M.D. Anderson Cancer CenterBellicum PharmaceuticalsRecruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | CD19 PositiveUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingMelanoma | Metastatic Melanoma | TumorUnited States
-
M.D. Anderson Cancer CenterRecruitingAdenocarcinoma | Pancreatic Cancer | Ovarian CancerUnited States
-
M.D. Anderson Cancer CenterRecruitingAdvanced Renal Cell Carcinoma | Advanced Mesothelioma | Advanced OsteosarcomaUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
M.D. Anderson Cancer CenterRecruitingB-Cell Lymphoma | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML)United States
-
M.D. Anderson Cancer CenterCompletedChronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | B-Lymphoid Malignancies | Non-hodgkin LymphomaUnited States